THERANOSTICS 2016*
Chairs: Harvey Turner & John Babich
The success and failure of Radioimmunotherapy for Lymphoma (#40)
10:30 AM
PSMA in Breast Cancer (#41)
10:50 AM
Theranostics for the invasive cancer phenotype: uPAR targeted theranostics (#42)
11:10 AM
Optimizing Theranostics Through Pretargeting Approaches (#43)
11:30 AM
Initial South African experience on 68Ga/213Bi radiolabeling for prospective theranostics (#44)
11:50 AM
Critical Aspects of Radiochemical Purity Determination of 68Ga-BCA-Peptides and Behavioral Features of Different 68Ga Species (#45)
12:05 PM
Glioma tumors grade II/III – local alpha emiters targeted therapy with 213Bi-DOTA-substance P (#46)
12:20 PM
Spatially informed dose deposition of Auger electron-emitting radionuclides at a cell nucleus scale (#47)
12:35 PM